This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


Advertisement


Mobile version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us   May. 10, 2013


Advertisement

Advertisement

Advertisement
 

Advertisement


Just 10 days left! Cast your vote now!
Eligible AST members have 10 days left to cast their votes for the AST Board of Directors, as well as various bylaw revisions. The voting site will prompt you to login to the AST website where you will find more detailed information. Usernames and passwords were previously sent to eligible members. Election results will be announced at the AST Town Hall meeting at ATC on Monday, May 20, at 5:45 p.m. in Room 3 A/B of the Washington State Convention Center. Email Nicole Poponi, AST Director of Membership, with questions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Advertisement


SOCIETY NEWS


The AST needs your help
The AST is only as strong as our members, so we are asking for your help in supporting the AST Endowment if you have not already done so this year. The Endowment Fund has made it possible for the society to subsidize programs that are core to our mission, such as funding for research grants and education for the next generation of transplant professionals at our annual fellows symposium.

In a time when funding from external sources is declining, any contribution, great or small, is very much appreciated. And you can be confident that 100 percent of your contribution will go directly to the endowment. Make a contribution today!

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Save the Date for AST's Cutting Edge of Transplantation 2014
Are we on the right track with new drugs and biologics? Have the targets changed? Where can we really impact outcomes with "technology-omics?" The time has come to integrate our strategies, therapies and technology, and critically assess their merits as we face the enormous task of extending transplant survival. Save the date for the 2014 AST Cutting Edge of Transplantation where expert clinicians, leading diagnosticians, and world class scientists will address this enormous challenge together with an engaged audience.

When: Feb. 13-16, 2014
Where: Sheraton Wild Horse Pass, Chandler, Ariz.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
FEATURED ADVERTISER
 
Innovation in Surgical Retraction

Thompson Surgical Instruments, Inc. is the market leader in surgical retraction and the manufacturer of the original table mounted retractor. For more information, visit our website at thompsonsurgical.com or email us at info@thompsonsurgical.com.
 


AST @ ATC


AST Endowment donors: Get your ribbon for ATC!
If you donated to the AST Endowment in 2012 or 2013, please stop by the AST Membership Booth (booth # 701) during ATC to receive an Endowment Contributor ribbon for your ATC badge.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Attention job seekers: Participate in AST's Career Connections at ATC
Are you currently looking for a new position in the field of transplantation? Will you be attending the ATC in Seattle? Then we encourage you to browse AST's Career Center for open jobs and participate in the ATC Career Connections Event! All job postings with the ATC logo next to them indicate that the employer will also be attending ATC. These employers are looking to potentially interview candidates they are interested in while both parties are at the meeting. Should an employer wish to meet with you face-to-face, they will coordinate a mutually convenient time, and AST will provide a space for the interview to be conducted. Click here to learn more about this opportunity. If you have any questions, please contact the AST National Office at info@myAST.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Advertisement


AST Town Hall Meeting: Many voices, one goal
AST members are invited to attend a Town Hall meeting at ATC on Monday, May 20 at 5:45 p.m. in room 3 A/B at the Washington State Convention Center. The Town Hall will provide a forum for open discussion between the membership and the leadership about key issues impacting the Society and field of transplantation, and how the Society is positioned to address those key issues. In addition, we'll announce the Board of Director election results, recognize and honor AST volunteer leadership, and award the 2013 research grants. RSVP for the Town Hall/Excellence in Transplantation Reception here.

If you are not already an AST member and are interested in learning more, click here to complete an online membership application.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Stop in at AST events!
AST is hosting a variety of meetings and events at ATC, and you're invited! Click here for a list of events open to both members and non-members. Contact Jason Polinsky with questions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Featured Advertisers


Advertisement
Astellas Pharma US, Inc.

Astellas Pharma US, Inc., a U.S. affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the health of people around the world through innovative and reliable pharmaceutical products. For more information about Astellas Pharma US, Inc., please visit our Web site at www.astellas.us
Advertisement
New LIFECODES SSO Typing Kits

LIFECODES is introducing its new HLA-SSO kits. The new kit includes a validated, high-performance enzyme for improved reliability and performance with the continued ease of no centrifugation or wash steps; providing accurate, clear and easy to interpret results.
Advertisement
Genzyme


Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. MORE


TRANSPLANT NEWS


Lung transplant: Jump to top of list may carry risk
MedPage Today
An acute increase in lung allocation score (LAS) of more than 5 units in the month before lung transplant is a strong and independent predictor of post-transplant death, according to a new study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Concept of 'awake venovenous extracorporeal membrane oxygenation' in pediatric patients awaiting lung transplantation
Pediatric Transplantation (subscription required)
In patients awaiting LuTx, MV and ECMO are often the last ways to create a bridge to LuTx. Both interventions are associated with a poor posttransplant outcome and survival rate. To improve the results of these patients, new "bridging-strategies" are necessary. Recent reports demonstrate promising results for the concept of "awake ECMO" in adult patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement


Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: A world-wide survey
Liver Transplantation (subscription required)
The incidence of morbidity and mortality after living donor liver transplantation (LDLT) is not well understood because reporting is not standardized and relies on single-center reports. Aborted hepatectomies (AHs) and potentially life-threatening near-miss events (during which a donor's life may be in danger but after which there are no long-term sequelae) are rarely reported. A recent survey was conducted to determine the incidence of these events.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Groundbreaking surgery for girl born without windpipe (The New York Times)
Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineruin inhibitor-free regimen (Clinical Transplantation)
Everolimus-based immunosuppression post-liver transplant as effective as tacrolimus with better renal function (Healio)

Don't be left behind. Click here to see what else you missed.


Featured Advertisers


Advertisement
Put Science on Your Side

Drug Monitoring Platforms since 1981.

Learn More
Advertisement
Exclusively Focused Transplant Pharmacy Therapeutics
Transplant IV Biologics and Oral Immunosuppressives specializing in Desensitization and AMR Treatment and Prevention. MORE


Testing for HCV infection: An update of guidance for clinicians and laboratorians
Centers for Disease Control and Prevention
In the United States, an estimated 4.1 million persons have been infected with hepatitis C virus (HCV), of whom an estimated 3.2 (95 percent confidence interval [CI] = 2.7–3.9) million are living with the infection. New infections continue to be reported particularly among persons who inject drugs and persons exposed to HCV-contaminated blood in healthcare settings with inadequate infection control.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Antihypertensive pharmacotherapy and long-term outcomes in pediatric kidney transplantation
Clinical Transplantation
Hypertension (HTN) is common in pediatric recipients following kidney transplantation (KT). Researchers retrospectively assessed the impact of HTN on long-term (more than 10 year) outcomes in pediatric KT recipients (aged less than 18 yr) at our center. Two hundred and 93 pediatric KT recipients (83 percent living donor [LD]) with graft survival (GS) for less than or equal to 5 year were studied.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement


Survival improving for kids on dialysis
MedPage Today
Overall survival among children with end-stage renal disease who are being treated with dialysis has greatly improved over the last 20 years, researchers said here.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation
Clinical Transplantation
Biliary strictures (BS) remain a significant problem following liver transplantation (LT), representing an important cause of morbidity. The purpose of this follow-up study was to evaluate the incidence and risk factors associated with BS after LT.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Courtney Hodges, Content Editor, 972.402.2604   
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
May 3, 2013
April 26, 2013
April 19, 2013
April 12, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063